
    
      A Randomized, Single Blind, Single Dose, Placebo-controlled, Dose-escalation Phase I Study to
      Investigate the Pharmacokinetics, Safety, and Tolerability of Intradermal Dosage Form of
      BMT101 in Healthy Male Volunteers
    
  